IMARA (NASDAQ:IMRA – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday, Zacks.com reports. The brokerage presently has a $1.50 price objective on the stock. Zacks Investment Research‘s price objective would indicate a potential upside of 30.43% from the company’s current price. […]
Related Keywords
Boston , Massachusetts , United States , Braden Michael Leonard , Securities Exchange Commission , Goldman Sachs Group Inc , Zacks Investment Research , Nasdaq , Company Profile Get Rating , York Mellon Corp , Enterprise Associates , Cubist Systematic Strategies , Imara Inc , Millennium Management , Citigroup , Get Rating , Investment Research , Exchange Commission , Systematic Strategies , New York Mellon Corp , Goldman Sachs Group , Sachs Group , Himara , Nasdaq Imra , Timra , Medical , Upgrade ,
comparemela.com © 2020. All Rights Reserved.